Bank of New York Mellon’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Bank of New York Mellon’s Portfolio FMTX Stock Details FMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-125,574	Closed	-$2.51M	–	4626
2022 Q3	$2.51M	Buy	125,574 +21,616	+21%	+$285K	﹤0.01%	2695
2022 Q2	$716K	Sell	103,958 -11,332	-10%	-$79.5K	﹤0.01%	3370
2022 Q1	$1.07M	Sell	115,290 -925	-0.8%	-$9.85K	﹤0.01%	3262
2021 Q4	$1.65M	Buy	116,215 +3,177	+3%	+$55K	﹤0.01%	3111
2021 Q3	$2.62M	Buy	113,038 +15,373	+16%	+$363K	﹤0.01%	2839
2021 Q2	$2.43M	Buy	97,665 +9,438	+11%	+$254K	﹤0.01%	2867
2021 Q1	$2.47M	Buy	88,227 +27,173	+45%	+$980K	﹤0.01%	2809
2020 Q4	$2.13M	Buy	61,054 +14,860	+32%	+$647K	﹤0.01%	2812
2020 Q3	$2.3M	Buy	+46,194	New	+$1.87M	﹤0.01%	2587

Bank of New York Mellon's FMTX Position: Q4 2022 in Review

Bank of New York Mellon sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 125,574 shares — an estimated $2.51M sold.

Bank of New York Mellon first reported a position in FMTX in Q3 2020 and held it in 9 quarters. The position peaked at $2.62M in Q3 2021. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

Bank of New York Mellon reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Bank of New York Mellon sold 125,574 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $2.51M.
Bank of New York Mellon first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q3 2020 and held it in 9 quarters.
Bank of New York Mellon's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $2.62M in Q3 2021.
0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on Bank of New York Mellon's 13F filing for Q4 2022, filed 14 Feb 2023.